M. Bowling

Atrasentan, a n E ndothelin-Recep tor A ntagonist f or Refractory A denocarcinomas: S afety a nd P harmacokinetics

J. Nelson, M. Carducci, R. Donehower, 2013 .

Atrasentan, an endothelin-receptor antagonist for refractory adenocarcinomas: safety and pharmacokinetics.

J. Nelson, M. Carducci, R. Donehower, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Genetic analysis of cyclic nucleotide phosphodiesterases in Drosophila melanogaster.

R. Davis, H. Salz, J. Kiger, 1981, Advances in cyclic nucleotide research.